1. Wu YY, Luo YY, Huang LF, Wang HJ, Gao XB, Sun J, Chen J. Prevalence, and risk factors of medication non-adherence in children with inflammatory bowel disease. Chinese Journal of Pediatrics. 2022;60(11):1191-5. [DOI:10.3760/cma.j.cn112140-20220110-00036 [Link]]

2. Jang HJ, Kang B, Choe BH. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Translational Pediatrics. 2019;8(1):4-15. https://doi.org/10.21037/tp.2018.12.04 [DOI:10.21037/tp.2018.12.04 [Link]]

3. Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: current knowledge, challenges and opportunities. World journal of gastroenterology. 2018;24(21):2211. https://doi.org/10.3748/wjg.v24.i21.2211 [DOI:10.3748/wjg.v24.i21.22 11 [Link]]

4. Sheykhangafshe FB, Farahani H, Dehghani M, Fathi-Ashtiani A. The effectiveness of psychological interventions in the treatment of children and adolescents with chronic Pain: A systematic review. J Child Ment Health 2024; 11(1):5. [Persian] [DOI:10.61186/ jcmh.11.1.6 [Link]]

5. Devanarayana NM, Rajindrajith S, Pathmeswaran A, Abegunasekara C, Gunawardena NK, Benninga MA. Epidemiology of irritable bowel syndrome in children and adolescents in Asia. Journal of pediatric gastroenterology and nutrition. 2015;60(6):792-8. https://doi.org/10.1097/MPG.0000000000000714 [DOI:10.1097/ MPG.0000000000000702 [Link]]

6. Roberts SE, Thorne K, Thapar N, Broekaert I, Benninga MA, Dolinsek J, Mas E, Miele E, Orel R, Pienar C, Ribes-Koninckx C. A systematic review and meta-analysis of pediatric inflammatory bowel disease incidence and prevalence across Europe. Journal of Crohn's and Colitis. 2020;14(8):1119-48. https://doi.org/10.1093/ecco-jcc/jjaa037 [DOI:10.1093/ecco-jcc/jjaa0 24 [Link]]

7. Olfatifar M, Zali MR, Pourhoseingholi MA, Balaii H, Ghavami SB, Ivanchuk M, Ivanchuk P, Nazari SH, Shahrokh S, Sabour S, Khodakarim S. The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study. BMC Gastroenterology. 2021;21(1):204. https://doi.org/10.1186/s12876-021-01745-1 [DOI:10.1186/s12876-021-01784 -7 [Link]]

8. Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K. The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD. Journal of the Canadian Association of Gastroenterology. 2019;2(1):49-67. https://doi.org/10.1093/jcag/gwy056 [DOI:10.1093/jcag/gwy056 [Link]]

9. Butwicka A, Olén O, Larsson H, Halfvarson J, Almqvist C, Lichtenstein P, Serlachius E, Frisén L, Ludvigsson JF. Association of childhood-onset inflammatory bowel disease with risk of psychiatric disorders and suicide attempt. JAMA pediatrics. 2019;173(10):969-78. https:// doi.org/10.1001/jamapediatrics.2019.2537 [Link] [DOI:10.1001/jamapediatrics.2019.2662]

10. Bramuzzo M, De Carlo C, Arrigo S, Pavanello PM, Canaletti C, Giudici F, Agrusti A, Martelossi S, Di Leo G, Barbi E. Parental psychological factors and quality of life of children with inflammatory bowel disease. Journal of pediatric gastroenterology and nutrition. 2020;70(2):211-7. https://doi.org/10.1097/MPG.0000000000002572 [DOI:10.1097/MPG.0000000000002572 [Link]]

11. Porcelli P, De Carne M, Leandro G. Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome. Comprehensive psychiatry. 2014;55(7):1647-53. https://doi.org/10.1016/j.comppsych.2014.05.022 [DOI:10.1016/j.comppsych. 2014.06.007 [Link]]

12. Kano M, Muratsubaki T, Yagihashi M, Morishita J, Mugikura S, Dupont P, Takase K, Kanazawa M, Van Oudenhove L, Fukudo S. Insula activity to visceral stimulation and endocrine stress responses as associated with alexithymia in patients with irritable bowel syndrome. Psychosomatic medicine. 2020;82(1):29-38. https://doi. org/10.1097/PSY.0000000000000737 [Link] [DOI:10.1097/PSY.0000000000000729]

13. Fournier A, Mondillon L, Luminet O, Canini F, Mathieu N, Gauchez AS, Dantzer C, Bonaz B, Pellissier S. Interoceptive abilities in inflammatory bowel diseases and irritable bowel syndrome. Frontiers in psychiatry. 2020; 11:229. https://doi.org/10.3389/fpsyt.2020.00229 [DOI:10.3389/fpsyt.2020.00229 [Link]]

14. Carrozzino D, Porcelli P. Alexithymia in Gastroenterology and Hepatology: A Systematic Review. Frontiers in psychology. 2018 [DOI:10.3389/fpsyg.2018.00470]

15. 9:470. https://doi.org/10.3389/fpsyg [DOI:10.3389/fpsyg. 2018.00470 [Link]]

16. Porcelli P, De Carne M, Leandro G. The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome. Comprehensive Psychiatry. 2017; 73:127-35. https://doi. org/10.1016/j.comppsych.2016.11.003 [Link] 10.1016/j.comppsych.2016.11.010 []

17. Martino G, Caputo A, Schwarz P, Bellone F, Fries W, Quattropani MC, Vicario CM. Alexithymia and inflammatory bowel disease: a systematic review. Frontiers in Psychology. 2020; 11:1763. https://doi.org/10.3389/fpsyg.2020.01763 [DOI:10.3389/ fpsyg.2020.01763 [Link]]

18. Melehin AI. The role of gastrointestinal specific anxiety and alexithymia as predictors of the severity of irritable bowel syndrome in women. Neurology Bulletin. 2021;53(1):34-40. [Link] [DOI:10.17816/nb57154]

19. Lenzo V, Quattropani MC. Defense mechanisms and alexithymia in Inflammatory bowel disease and Irritable bowel disease. Journal of Clinical & Developmental Psychology. 2019;1(1): 41-49. [DOI:10.6092/ 2612-4033/0110-2089 [Link]]

20. Touny AA, Kenny E, Månsson M, Webb DL, Hellström PM. Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics. Scandinavian Journal of Gastroenterology. 2022;57(7):783-91. https://doi.org/10.1080/00365521.2022.2041084 [DOI:10.1080/00365521.202 2.2060350 [Link]]

21. Mujagic Z, Keszthelyi D, Aziz Q, Reinisch W, Quetglas EG, De Leonardis F, Segerdahl M, Masclee AA. Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Alimentary pharmacology & therapeutics. 2015;42(9):1064-81. https://doi.org/10.1111/apt.13378 [DOI:10.1111 /apt.13379 [Link]]

22. Morrison G, Van Langenberg DR, Gibson SJ, Gibson PR. Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort. Inflammatory bowel diseases. 2013;19(6):1210-7. https://doi.org/10.1097/MIB.0b013e318280e729 [DOI:10. 1097/MIB.0b013e318280b673 [Link]]

23. Sweeney L, Moss‐Morris R, Czuber‐Dochan W, Meade L, Chumbley G, Norton C. Systematic review: psychosocial factors associated with pain in inflammatory bowel disease. Alimentary pharmacology & therapeutics. 2018;47(6):715-29. https://doi.org/10.1111/apt.14529 [DOI:10.1111/apt.14529 [Link]]

24. Hollier JM, van Tilburg MA, Liu Y, Czyzewski DI, Self MM, Weidler EM, Heitkemper M, Shulman RJ. Multiple psychological factors predict abdominal pain severity in children with irritable bowel syndrome. Neurogastroenterology & Motility. 2019;31(2): e13509. https://doi.org/10.1111/nmo.13509 [DOI:10.1111/nmo.13509 [Link]]

25. Bakshi N, Hart AL, Lee MC, Williams AC, Lackner JM, Norton C, Croft P. Chronic pain in patients with inflammatory bowel disease. Pain. 2021;162(10):2466. https://doi.org/10.1097/j.pain.0000000000002241 [DOI:10.1097/j.pain.0000000000002241 [Link]]

26. Fukudo S. Irritable bowel syndrome, emotion regulation, and gut microbiota. Brain and Nerve= Shinkei Kenkyu no Shinpo. 2016;68(6):607-15. [DOI:10.11477/mf.1 416200356 [Link]]

27. Smith R, Gudleski GD, Lane RD, Lackner JM. Higher emotional awareness is associated with reduced pain in irritable bowel syndrome patients: Preliminary results. Psychological Reports. 2020;123(6):2227-47. https://doi.org/ 10.1177/0033294119889587 [Link] https://doi.org/10.1177/0033294119868778 [DOI:10.1177/0033294119889587 [Link]]

28. Li J, Yuan B, Li G, Lu X, Guo Y, Yang Y, Liang M, Ding J, Zhou Q. Convergent syndromic atrophy of pain and emotional systems in patients with irritable bowel syndrome and depressive symptoms. Neuroscience letters. 2020; 723:134865. https://doi.org/10.1016/j.neulet.2020.134865 [DOI:10.1016/j.neulet.2020 .134865 [Link]]

29. Janssens KA, Zijlema WL, Joustra ML, Rosmalen JG. Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the LifeLines cohort study. Psychosomatic medicine. 2015;77(4):449-57. https://doi.org/10.1097/PSY.0000000000000161 [DOI:10.1097/psy.000000000 0000161 [Link]]

30. Trindade IA, Ferreira C, Pinto‐Gouveia J. The longitudinal effects of emotion regulation on physical and psychological health: A latent growth analysis exploring the role of cognitive fusion in inflammatory bowel disease. British journal of health psychology. 2018;23(1):171-85. https://doi.org/10.1111/bjhp.12281 [DOI:10.1111/bjhp.12281 [Link]]

31. Trindade IA, Ferreira C, Pinto-Gouveia J. Shame and emotion regulation in inflammatory bowel disease: Effects on psychosocial functioning. Journal of Health Psychology. 2020;25(4):511-21. https://doi.org/10.1177/1359105317718925 [DOI:10.1177/135910531771 8924 [Link]]

32. Berens S, Schaefert R, Ehrenthal JC, Baumeister D, Eich W, Tesarz J. Different dimensions of affective processing in patients with irritable bowel syndrome: A multi-center cross-sectional study. Frontiers in Psychology. 2021; 12:625381. https://doi.org/10.3389/fpsyg.2021.625381 [DOI:10.3389/fpsyg.2021.625381 [Link]]

33. Sheykhangafshe FB, Mohammadi Sangachin Doost A, Savabi Niri V, Mojez N, Bourbour Z. The Efficacy of Cognitive-Behavioral Group Therapy on Psychological Well-being and Resilience of Students with Depressive Syndrome. J Child Ment Health 2023; 10(1):8. [Persian] https://doi.org/10.61186/jcmh.10.1.9 [DOI:10.61186/jcmh.10.1.9 [Link]]

34. Ahola Kohut S, Stinson J, Jelen A, Ruskin D. Feasibility and acceptability of a mindfulness-based group intervention for adolescents with inflammatory bowel disease. Journal of Clinical Psychology in Medical Settings. 2020; 27:68-78. https://doi.org/10.1007/s10880-019-09622-6 [DOI:10.1007/s10880-019-09628-5 [Link]]

35. Ballou S, Keefer L. Psychological interventions for irritable bowel syndrome and inflammatory bowel diseases. Clinical and translational gastroenterology. 2017;8(1):214. https: //doi.org/10.1038/ctg.2017.3 [Link] [DOI:10.1038/ctg.2016.69]

36. Bredero QM, Fleer J, Smink A, Kuiken G, Potjewijd J, Laroy M, Visschedijk MC, Russel M, van der Lugt M, Meijssen MA, van der Wouden EJ. Mindfulness-Based Cognitive Therapy for Fatigue in Patients with Inflammatory Bowel Disease: Results of a Randomized Controlled Trial. Mindfulness. 2023:1-4. [DOI:1 0.1007/s12671-022-02014-7 [Link]]

37. Ewais T, Begun J, Kenny M, Hay K, Houldin E, Chuang KH, Tefay M, Kisely S. Mindfulness-based cognitive therapy for youth with inflammatory bowel disease and depression-Findings from a pilot randomized controlled trial. Journal of psychosomatic research. 2021; 149:110594. https://doi.org/10.1016/j.jpsychores.2021.110594 [DOI:10.1016/j.jpsychores.2021.110594 [Link]]

38. Henrich JF, Gjelsvik B, Surawy C, Evans E, Martin M. A randomized clinical trial of mindfulness-based cognitive therapy for women with irritable bowel syndrome-Effects and mechanisms. Journal of consulting and clinical psychology. 2020;88(4):295. https://doi.org/10.1037/ccp0000483 [DOI:10.1037/ccp0 000461 [Link]]

39. Ewais T, Begun J, Kenny M, Rickett K, Hay K, Ajilchi B, Kisely S. A systematic review and meta-analysis of mindfulness-based interventions and yoga in inflammatory bowel disease. Journal of psychosomatic research. 2019; 116:44-53. https://doi.org/10.1016/j.jpsychores.2018.11.010 [DOI:10.1016/j.jpsychores.2018.11 .013 [Link]]

40. Faul F, Erdfelder E, Lang AG, & Buchner A. G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007; 39(2): 175-191. https://doi.org/10.3758/BF03193146 [DOI:10.3758/BF03193146 [Link]]

41. Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity. Journal of psychosomatic research. 1994;38(1):33-40. https://doi.org/10.1016/0022-3999(94)90006-X [DOI:10.1016/0022-3999(94) 90006-X [Link]]

42. Sheykhangafshe FB, Fathi-Ashtiani A, Savabi Niri V, Rezaei Golezani H, Baryaji S. The Effectiveness of Acceptance and Commitment Therapy on Anxiety Sensitivity and Alexithymia of Nurses with Chronic Low Back Pain. TB 2023; 21 (5): 49-63. [Persian] [DOI:10.18502/ tbj.v21i5.11751 [Link]]

43. Von Korff M, Scher AI, Helmick C, Carter-Pokras O, Dodick DW, Goulet J, Hamill-Ruth R, LeResche L, Porter L, Tait R, Terman G. United States national pain strategy for population research: concepts, definitions, and pilot data. The Journal of Pain. 2016;17(10):1068-80. https://doi.org/10.1016/j.jpain.2016.06.009 [DOI:10.1016/j.jpai n.2016.06.009 [Link]]

44. Shirazitehrani A, Mirdrikvand F, Sepahvandi M A. Development of Structural model for predicting chronic musculoskeletal pain by pain disposition, Catastrophizing, fear, pain intensity and inability. JAP 2017; 8 (2):92-106. [Link]

45. Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. Journal of personality and social psychology. 2003;85(2):348. https://doi.org/10.1037/0022-3514.85.2.348 [DOI:10.1037/0022-3514.85.2.348 [Link]]

46. Sheykhangafshe FB, Kiani A, Savabi-Niri V, Aghdasi N, Bourbour Z. The efficacy of acceptance and commitment therapy on psychological capital and emotion regulation of students with suicidal ideation. IJBS. 2022;16(2):96-102. [DOI:10.30491/IJBS.2022.321757.1944 [Link]]

47. Segal Z, Williams M, Teasdale J. Mindfulness-based cognitive therapy for depression. Guilford Publications; 2018. [Link]